Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

583 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.
Lurie G, Wilkens LR, Thompson PJ, Carney ME, Palmieri RT, Pharoah PD, Song H, Hogdall E, Kjaer SK, DiCioccio RA, McGuire V, Whittemore AS, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Goodman MT; Ovarian Cancer Association Consortium. Lurie G, et al. Among authors: thompson pj. Int J Cancer. 2011 Feb 15;128(4):936-43. doi: 10.1002/ijc.25403. Int J Cancer. 2011. PMID: 20473893 Free PMC article. Clinical Trial.
Calcitonin gene polymorphism CALCA-624 (T/C) and ovarian cancer.
Goodman MT, Ferrell R, McDuffie K, Thompson PJ, Wilkens LR, Bushley AW, Tung KH, Carney ME, Ness RB. Goodman MT, et al. Among authors: thompson pj. Environ Mol Mutagen. 2005 Jul;46(1):53-8. doi: 10.1002/em.20134. Environ Mol Mutagen. 2005. PMID: 15880427
Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY, Goodman MT. Lurie G, et al. Among authors: thompson pj. Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2566-71. doi: 10.1158/1055-9965.EPI-07-0753. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 18086759
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.
Schildkraut JM, Goode EL, Clyde MA, Iversen ES, Moorman PG, Berchuck A, Marks JR, Lissowska J, Brinton L, Peplonska B, Cunningham JM, Vierkant RA, Rider DN, Chenevix-Trench G, Webb PM, Beesley J, Chen X, Phelan C, Sutphen R, Sellers TA, Pearce L, Wu AH, Van Den Berg D, Conti D, Elund CK, Anderson R, Goodman MT, Lurie G, Carney ME, Thompson PJ, Gayther SA, Ramus SJ, Jacobs I, Krüger Kjaer S, Hogdall E, Blaakaer J, Hogdall C, Easton DF, Song H, Pharoah PD, Whittemore AS, McGuire V, Quaye L, Anton-Culver H, Ziogas A, Terry KL, Cramer DW, Hankinson SE, Tworoger SS, Calingaert B, Chanock S, Sherman M, Garcia-Closas M; Australian Ovarian Cancer Study Group. Schildkraut JM, et al. Among authors: thompson pj. Cancer Res. 2009 Mar 15;69(6):2349-57. doi: 10.1158/0008-5472.CAN-08-2902. Epub 2009 Mar 10. Cancer Res. 2009. PMID: 19276375 Free PMC article.
583 results